Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Scheinin

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Synapse (New York, N.Y.)|July 12, 2002
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in manNora Hagelberg, Jaana K Kajander, Kjell Någren, et al.
Pain|January 1, 1985
Neurotransmission and the experience of low back pain; no association between CSF monoamine metabolites and painMarkku T Hyyppä, Harry Scheinin, Hannu Alaranta, et al.
Plos One|November 25, 2014
Directional connectivity between frontal and posterior brain regions is altered with increasing concentrations of propofolAnu Maksimow, Minna Silfverhuth, Jaakko Långsjö, et al.
Methods in Enzymology|April 21, 2018
Using Positron Emission Tomography in Revealing the Mystery of General Anesthesia: Study Design Challenges and OpportunitiesHarry Scheinin, Emilee C Alkire, Annalotta Scheinin, et al.
Synapse (New York, N.Y.)|November 13, 2015
Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070Jussi Lehto, Annalotta Scheinin, Jarkko Johansson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 19, 2004
Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylatorsSaila Antila, Ullamari Pesonen, Lasse Lehtonen, et al.
Journal of Nuclear Medicine Technology|June 4, 2004
Ventilator add-on for delivering PET tracer gasesKaike K Kaisti, Jukka Mäkitalo, Hannu T Sipilä, et al.
Neuroscience Letters|February 22, 2005
Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesiaIlkka K Martikainen, Nora Hagelberg, Heikki Mansikka, et al.
The European Journal of Neuroscience|September 10, 2004
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to painAntti Pertovaara, Ilkka K Martikainen, Nora Hagelberg, et al.
European Journal of Clinical Pharmacology|January 20, 2004
Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokineticsKari Laine, Steven De Bruyn, Harry Björklund, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Synapse (New York, N.Y.)|July 12, 2002
Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in manNora Hagelberg, Jaana K Kajander, Kjell Någren, et al.
Pain|January 1, 1985
Neurotransmission and the experience of low back pain; no association between CSF monoamine metabolites and painMarkku T Hyyppä, Harry Scheinin, Hannu Alaranta, et al.
Plos One|November 25, 2014
Directional connectivity between frontal and posterior brain regions is altered with increasing concentrations of propofolAnu Maksimow, Minna Silfverhuth, Jaakko Långsjö, et al.
Methods in Enzymology|April 21, 2018
Using Positron Emission Tomography in Revealing the Mystery of General Anesthesia: Study Design Challenges and OpportunitiesHarry Scheinin, Emilee C Alkire, Annalotta Scheinin, et al.
Synapse (New York, N.Y.)|November 13, 2015
Detecting a dexmedetomidine-evoked reduction of noradrenaline release in the human brain with the alpha2C-adrenoceptor PET ligand [11C]ORM-13070Jussi Lehto, Annalotta Scheinin, Jarkko Johansson, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 19, 2004
Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylatorsSaila Antila, Ullamari Pesonen, Lasse Lehtonen, et al.
Journal of Nuclear Medicine Technology|June 4, 2004
Ventilator add-on for delivering PET tracer gasesKaike K Kaisti, Jukka Mäkitalo, Hannu T Sipilä, et al.
Neuroscience Letters|February 22, 2005
Association of striatal dopamine D2/D3 receptor binding potential with pain but not tactile sensitivity or placebo analgesiaIlkka K Martikainen, Nora Hagelberg, Heikki Mansikka, et al.
The European Journal of Neuroscience|September 10, 2004
Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to painAntti Pertovaara, Ilkka K Martikainen, Nora Hagelberg, et al.
European Journal of Clinical Pharmacology|January 20, 2004
Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokineticsKari Laine, Steven De Bruyn, Harry Björklund, et al.
Pageof 9